Thousands of women battling advanced breast cancer could be denied access to crucial life-extending medication due to an ...

Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead's Trodelvy and Novartis' Piqray – in England. In a ...

Prostate cancer has become the most commonly diagnosed cancer in England, with Sky News' Dermot Murnaghan sharing his stage ...

Approved by the Medicines and Healthcare products Regulatory Agency (MHRA), the injectable will cut down on immunotherapy ...

A mum who has breast cancer is one of thousands of women who could be "missing out" on life-extending drugs because of the way they are assessed by the health service, a charity has warned. Breast ...

The Personalised Breast Cancer Programme (PBCP) is now available at James Paget University Hospital in Gorleston. The PBCP uses whole genome sequencing to analyse tumour DNA and identify genetic ...

The test may be able to personalise chemotherapy, preventing patients from potentially going through the harsh treatment for ...

Cancer Research UK-funded scientists at the University of Cambridge, in collaboration with the Spanish National Cancer ...